0001127602-24-009000.txt : 20240307
0001127602-24-009000.hdr.sgml : 20240307
20240307160516
ACCESSION NUMBER: 0001127602-24-009000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desjarlais John R
CENTRAL INDEX KEY: 0001591313
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 24730028
MAIL ADDRESS:
STREET 1: C/O XENCOR, INC.
STREET 2: 111 WEST LEMON AVENUE
CITY: MONROVIA
STATE: CA
ZIP: 91016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-05
0001326732
Xencor Inc
XNCR
0001591313
Desjarlais John R
C/O XENCOR, INC.
465 N HALSTEAD STREET, SUITE 200
PASADENA
CA
91107
1
SR. VICE PRESIDENT & CSO
0
Common Stock
2024-03-05
4
S
0
6629
23.429
D
166989
D
Common Stock
2024-03-05
4
A
0
20724
0
A
187713
D
Stock Options
22.85
2024-03-05
4
A
0
124346
0
A
2034-03-04
Common Stock
124346
124346
D
Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 18,195 restricted stock units.
Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant.
25% of the shares subject to the option shall vest on the one year anniversary of March 5, 2024 (the "Vesting Commencement Date") and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.
/s/ Celia E. Eckert, Attorney-in-Fact
2024-03-06